MAR 12, 2015 3:35 PM PDT

Can green tea slow cancer in smokers?

WRITTEN BY: Robert Woodard
Camellia sinensis
A study by University of Illinois at Chicago researchers aims to determine whether green tea can inhibit the growth of cancer cells in smokers.

Green tea is made from leaves of the Camellia sinensis plant, which are heated after harvest to destroy enzymes that would break down catechins, natural antioxidant substances that may prevent or delay some types of cell damage. Combined with the caffeine found in tea, catechins - especially the most active and abundant one, epigallocatechin-3-gallate - has been shown in animal models to be effective in preventing lung and other cancers.

Guy Adami and Joel Schwartz, associate professors of oral medicine and diagnostic sciences in the UIC College of Dentistry, hope to see whether green tea can induce a protective process of cell death called apoptosis, which occurs when cells of a living organism are damaged, for example by carcinogens.

The researchers will analyze RNA collected from cells in the mouth and cheek of study participants to determine, based on gene expression, cell pathways that are regulated by moderate levels of green tea consumption.

To enroll in the study, subjects must be between the ages of 20 and 45; smoke more than 10 cigarettes per day; have smoked for at least five years; and are willing to drink five cups of green tea each day.

In an earlier study, Schwartz discovered increased apoptosis in cells taken from the tongue of tobacco smokers after a month of exposure to the catechins from green tea.

"We believe the cathechins found in green tea are a possible daily preventative approach for head and neck cancers," Adami said.

Source: UIC News Center
About the Author
You May Also Like
MAR 17, 2020
Cancer
MAR 17, 2020
Cancer and the risk of AFib
Research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of ...
APR 19, 2020
Drug Discovery & Development
APR 19, 2020
FDA Approves New Drug for Breast Cancer
The US Food and Drug Administration has approved a new drug, known as tucatinib or Tuksya, as a treatment for advanced f ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
Skin Deep: Handheld Device Sees the Earliest Signs of Cancer
Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater t ...
APR 21, 2020
Cancer
APR 21, 2020
Scientists develop tumor immunity map
A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecule ...
MAY 02, 2020
Drug Discovery & Development
MAY 02, 2020
Glioblastoma Treatment Using Schizophrenic Drug Plus Radiation
A therapeutic used for the treatment of schizophrenia could be a gateway for targeting glioblastoma, one of the deadlies ...
MAY 21, 2020
Cancer
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
Loading Comments...